SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Orthofix Medical Inc. – ‘10-Q’ for 6/30/16

On:  Monday, 8/1/16, at 4:16pm ET   ·   For:  6/30/16   ·   Accession #:  1564590-16-21905   ·   File #:  0-19961

Previous ‘10-Q’:  ‘10-Q’ on 4/28/16 for 3/31/16   ·   Next:  ‘10-Q’ on 10/31/16 for 9/30/16   ·   Latest:  ‘10-Q’ on 11/8/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/01/16  Orthofix Medical Inc.             10-Q        6/30/16   56:5.6M                                   ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    488K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
11: R1          Document and Entity Information                     HTML     39K 
12: R2          Condensed Consolidated Balance Sheets               HTML     89K 
13: R3          Condensed Consolidated Balance Sheets               HTML     30K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML    133K 
                and Comprehensive Income (Loss)                                  
15: R5          Condensed Consolidated Statements of Cash Flows     HTML     62K 
16: R6          Nature of operations, basis of presentation and     HTML     32K 
                recently issues accounting pronouncements                        
17: R7          Inventories                                         HTML     46K 
18: R8          Long-term debt                                      HTML     23K 
19: R9          Derivative instruments                              HTML     68K 
20: R10         Fair value measurements                             HTML    180K 
21: R11         Accumulated other comprehensive loss                HTML     71K 
22: R12         Earnings per share                                  HTML     58K 
23: R13         Share-based compensation                            HTML     26K 
24: R14         Income taxes                                        HTML     25K 
25: R15         Business segment information                        HTML    207K 
26: R16         Contingencies                                       HTML     48K 
27: R17         Share repurchase plan                               HTML     22K 
28: R18         Nature of operations, basis of presentation and     HTML     32K 
                recently issues accounting pronouncements                        
                (Policies)                                                       
29: R19         Inventories (Tables)                                HTML     46K 
30: R20         Derivative instruments (Tables)                     HTML     65K 
31: R21         Fair value measurements (Tables)                    HTML    172K 
32: R22         Accumulated other comprehensive loss (Tables)       HTML     67K 
33: R23         Earnings per share (Tables)                         HTML     55K 
34: R24         Business segment information (Tables)               HTML    203K 
35: R25         Nature of operations, basis of presentation and     HTML     21K 
                recently issues accounting pronouncements -                      
                Additional Information (Detail)                                  
36: R26         Inventories - Schedule of Inventories (Detail)      HTML     31K 
37: R27         Long-Term Debt - Additional Information (Detail)    HTML     35K 
38: R28         Derivative Instruments - Schedule of Fair Values    HTML     28K 
                of Derivative Instruments (Detail)                               
39: R29         Derivative Instruments - Schedule of Gain (Loss)    HTML     25K 
                Recognized in Other Comprehensive Income (Loss)                  
                (Detail)                                                         
40: R30         Fair Value Measurements - Schedule of Financial     HTML     53K 
                Assets and Liabilities Measured at Fair Value on                 
                Recurring Basis (Detail)                                         
41: R31         Fair Value Measurements - Additional Information    HTML     42K 
                (Detail)                                                         
42: R32         Fair Value Measurements - Schedule of               HTML     28K 
                Reconciliation of Debt Securities (Detail)                       
43: R33         Accumulated Other Comprehensive Loss - Components   HTML     46K 
                of Changes in Accumulated Other Comprehensive Loss               
                (Detail)                                                         
44: R34         Accumulated Other Comprehensive Loss - Components   HTML     35K 
                of Changes in Accumulated Other Comprehensive Loss               
                (Parenthetical) (Detail)                                         
45: R35         Earnings Per Share - Schedule of Reconciliation of  HTML     29K 
                Weighted Average Shares Used in Calculation of                   
                Basic and Diluted Net (Loss) Income Per Share                    
                (Detail)                                                         
46: R36         Earnings Per Share - Additional Information         HTML     28K 
                (Detail)                                                         
47: R37         Share-based Compensation - Additional Information   HTML     31K 
                (Detail)                                                         
48: R38         Income Taxes - Additional Information (Detail)      HTML     27K 
49: R39         Business Segment Information - Additional           HTML     20K 
                Information (Detail)                                             
50: R40         Business Segment Information - Schedule of Net      HTML     34K 
                Sales by SBU Reporting Segment (Detail)                          
51: R41         Business Segment Information - Summary of Net       HTML     53K 
                Margin as Gross Profit Less Sales and Marketing                  
                Expense by SBU Reporting Segment (Detail)                        
52: R42         Contingencies - Additional Information (Detail)     HTML     41K 
53: R43         Share Repurchase Plan - Additional Information      HTML     34K 
                (Detail)                                                         
55: XML         IDEA XML File -- Filing Summary                      XML     99K 
54: EXCEL       IDEA Workbook of Financial Reports                  XLSX     50K 
 5: EX-101.INS  XBRL Instance -- ofix-20160630                       XML   1.55M 
 7: EX-101.CAL  XBRL Calculations -- ofix-20160630_cal               XML    116K 
 8: EX-101.DEF  XBRL Definitions -- ofix-20160630_def                XML    272K 
 9: EX-101.LAB  XBRL Labels -- ofix-20160630_lab                     XML    639K 
10: EX-101.PRE  XBRL Presentations -- ofix-20160630_pre              XML    492K 
 6: EX-101.SCH  XBRL Schema -- ofix-20160630                         XSD    104K 
56: ZIP         XBRL Zipped Folder -- 0001564590-16-021905-xbrl      Zip     94K 




        
Filing Submission 0001564590-16-021905 – SGML Text

Original SGML Text submitted by:  ActiveDisclosure/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 6:05:18.2pm ET